BMP4 was shown to be downregulated in bladder cancer, where better progression-free survival (PFS) was observed in advanced ovarian cancer patients with strong expression of BMP-4 [30,31,32]. This evidence concerns the gene BMP4 and urinary bladder carcinoma.